MTOR and cancer: Chang et al. showed that tumor-infiltrating lymphocytes (TILs) compete with cancer cells for glucose, and when this metabolite is scarce, a downregulation of mTOR activity, glycolytic flux, and interferon-γ IFN-γ production by TILs is observed [219].